Profil
Veronica Byfield Sköld currently works at Clinical Laserthermia Systems AB, as Director from 2025 and Impilo AB, as Partner from 2017.
Ms. Byfield Sköld also formerly worked at Elekta AB, as VP-Product Commercialization Elekta Neuroscience from 2009 to 2016.
Aktive Positionen von Veronica Byfield Sköld
| Unternehmen | Position | Beginn |
|---|---|---|
| CLINICAL LASERTHERMIA SYSTEMS AB | Direktor/Vorstandsmitglied | 27.06.2025 |
Impilo AB
Impilo AB Investment ManagersFinance Impilo invests in both private and public companies located in Sweden with an enterprise value of EUR 50 - 200 million. The firm focuses on the healthcare sector or companies working in health-related industries. It provides financing for buyout transactions. It acquires minority or majority interest. It also makes ESG investments. | Private Equity Investor | 01.11.2017 |
Ehemalige bekannte Positionen von Veronica Byfield Sköld
| Unternehmen | Position | Ende |
|---|---|---|
| ELEKTA AB | Corporate Officer/Principal | 01.08.2016 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Elekta AB
Elekta AB Medical SpecialtiesHealth Technology Manufactures radiation oncology and neurosurgery instruments | Health Technology |
Clinical Laserthermia Systems AB
Clinical Laserthermia Systems AB Medical SpecialtiesHealth Technology Engages in developing, manufacturing, importing and trading of equipment for medical applications and related business | Health Technology |
Impilo AB
Impilo AB Investment ManagersFinance Impilo invests in both private and public companies located in Sweden with an enterprise value of EUR 50 - 200 million. The firm focuses on the healthcare sector or companies working in health-related industries. It provides financing for buyout transactions. It acquires minority or majority interest. It also makes ESG investments. | Finance |
















